Integrative Biomedical Research
Integrative Biomedical Research (Journal of Angiotherapy) | Online ISSN 3068-6326
558
Citations
1.3m
Views
728
Articles
Volume 10 Number 1 2026
RESEARCH ARTICLE (Open Access)
Predicting Parkinson’s Disease Progression Using Statistical And Neural Mixed Effects Models: Comparative Study On Longitudinal Biomarkers
Ran Tong 1*, Lanruo Wang 2, Tong Wang 3, Wei Yan 4
Integrative Biomedical Research 10 (1) 1-8 https://doi.org/10.25163/angiotherapy.10110648
Submitted: 25 February 2026 Revised: 18 February 2026 Accepted: 17 January 2026 Published: 27 February 2026
Abstract
Predicting Parkinson’s Disease (PD) progression is crucial for personalized treatment, and voice biomarkers offer a promising non-invasive method for tracking symptom severity through telemon- itoring. However, analyzing this longitudinal data is challenging due to inherent within-subject correlations, the small sample sizes typical of clinical trials, and complex patient-specific progres- sion patterns. While deep learning offers high theoretical flexibility, its application to small-cohort longitudinal studies remains under-explored compared to traditional statistical methods. This study presents an application of the Neural Mixed Effects (NME) framework to Parkinson’s telemonitoring, benchmarking it against Generalized Neural Network Mixed Models (GNMM) and semi-parametric Generalized Additive Mixed Models (GAMMs). Using the Oxford Parkinson’s telemonitoring voice dataset (N = 42), we demonstrate that while neural architectures offer flexibility, they are prone to significant overfitting in small-sample regimes. Our results indicate that GAMMs provide the optimal balance, achieving superior predictive accuracy (MSE 6.56) compared to neural baselines (MSE > 90) while maintaining clinical interpretability. We discuss the critical implications of these findings for developing robust, deployable telemonitoring systems where data scarcity is a constraint, highlighting the necessity for larger, diverse datasets for neural model validation.
Keywords: Parkinson’s Disease · Biostatistics · Longitudinal Data · Neural Networks · Artificial Intelligence
References
Alshammari, H., et al. (2025). Parkinson’s disease progression prediction using transformer-based time-series models and explainable AI. IEEE Access, 13, 147819–147830.
Ananthanarayanan, A., Senivarapu, S., & Murari, A. (2025). Towards causal interpretability in deep learning for parkinson’s detection from voice data. medRxiv. 2025.04.25.25326311.
Arora, S., Vetek, E. V., Hargrave, Z. B., et al. (2015). Detecting and monitoring the symptoms of parkinson’s disease using smartphones: a pilot study. Parkinsonism & Related Disorders, 21(6), 650–653.
Bloem, B. R., Post, M. R., & Dorsey, R. (2021). The expanding burden of parkinson’s disease. Journal of Parkinson’s Disease, 11(2), 403–413.
Breslow, N. E., & Clayton, D. G. (1993). Approximate inference in generalized linear mixed models. Journal of the American Statistical Association, 88(421), 9–25.
Del Din, S., Godfrey, A., & Rochester, L. (2016). Free-living gait characteristics in ageing and parkinson’s disease: impact of environment and ambulatory bout length. Journal of NeuroEngineering and Rehabilitation, 13, 46.
Dempster, A. P., Laird, N. M., & Rubin, D. B. (1977). Maximum likelihood from incomplete data via the EM algorithm.
Journal of the Royal Statistical Society: Series B (Methodological), 39(1), 1–22.
Dorsey, R., Bloem, B. R., et al. (2018). Global, regional, and national burden of parkinson’s disease, 1990–2016. The Lancet Neurology, 17(11), 939–953.
Drotar, P., Mekyska, M., & Ruzicka, I. (2016). Evaluation of handwriting kinematics and pressure for differential diagnosis of parkinson’s disease. Artificial Intelligence in Medicine, 67, 39–46.
Elkholy, G. R., et al. (2025). Enhanced LSTM with attention mechanism for early detection of parkinson’s disease through voice signals. arXiv preprint arXiv:2502.08672.
Eskidere, Ö., Ertas¸, F., & Hanilçi, C. (2012). A comparison of regression methods for remote tracking of parkinson’s disease progression. Expert Systems with Applications, 39(5), 5523–5528.
Fahn, S., Elton, R. L., & Members of the UPDRS Development Committee. (1987). Unified parkinson’s disease rating scale. In S. Fahn, C. D. Marsden, D. B. Calne, & M. Goldstein (Eds.), Recent Developments in Parkinson’s Disease (Vol. 2, pp. 153–163). Macmillan Healthcare Information.
Fereshtehnejad, S.-M., et al. (2017). Clinical criteria for subtyping parkinson’s disease: biomarkers and longitudinal progression. Brain, 140(7), 1959–1976.
Filali, Y., et al. (2023). Parkinson’s disease diagnosis using Laplacian score, Gaussian process regression and self- organizing maps. Diagnostics, 13(8), 1369.
Gilmour, A. R., Thompson, R., & Cullis, B. R. (1995). Average information REML: An efficient algorithm for variance parameter estimation in linear mixed models. Biometrics, 51(4), 1440–1450.
Goetz, C. G., Nguyen, S. T., et al. (2008). Movement disorder society-sponsored revision of the unified parkinson’s disease rating scale (MDS-UPDRS). Movement Disorders, 23(15), 2129–2170.
Hassan, T., et al. (2024). Comparing machine learning and deep learning models to predict cognition progression in parkinson’s disease. NPJ Digital Medicine, 7(1), 1–12.
Laird, N. M., & Ware, J. H. (1982). Random-effects models for longitudinal data. Biometrics, 38(4), 963–974.
Li, Y., Liu, S., Tong, R., Zhang, P., Bian, J., Wang, T., & Gu, P. (2025). Revolutionizing healthcare: The role of artificial intelligence in drug discovery and delivery. Journal of Angiotherapy, 9(1), 1–8.
Lin, X., & Zhang, D. (1999). Inference in generalized additive mixed models by using smoothing splines. Journal of the Royal Statistical Society: Series B, 61(2), 381–400.
Lindstrom, M. J., & Bates, D. M. (1990). Nonlinear mixed effects models for repeated measures data. Biometrics, 46, 673–687.
Maity, T. K., & Pal, A. K. (2013). Subject-specific treatment to neural networks for repeated measures analysis. In
Proceedings of the International MultiConference of Engineers and Computer Scientists (Vol. 1, pp. 60–65).
Mandel, F., Ghosh, R. P., & Barnett, I. (2023). Neural networks for clustered and longitudinal data using mixed effects models. Biometrics, 79(2), 711–721.
Nilashi, M., Ibrahim, O., & Ahani, A. (2016). Accuracy improvement for predicting parkinson’s disease progression.
Scientific Reports, 6.
Ortega, R. A., et al. (2021). Association of dual LRRK2 G2019S and GBA variations with parkinson disease progression.
JAMA Network Open, 4(4), e215845.
Patterson, H. D., & Thompson, R. (1971). Recovery of inter-block information when block sizes are unequal. Biometrika, 58(3), 545–554.
Paul, K. C., Chuang, Y. H., Bronstein, J. M., & Ritz, B. (2021). Lifestyle factors and parkinson’s disease risk.
Pharmacological Research, 173, 105911.
Pinho, P., et al. (2018). Impact of levodopa treatment in the voice pattern of parkinson’s disease patients: a systematic review and meta-analysis. CoDAS, 30(5), e20170200.
Rezaei, M., et al. (2024). LRP-enhanced LSTM model for interpretable prediction of parkinson’s disease progression.
Journal of Clinical Research and Data, 5(2), 29–46.
Ruppert, D., Wand, M. P., & Carroll, R. J. (2003). Semiparametric Regression. Cambridge University Press. Saunders-Pullman, R., et al. (2018). Progression in the LRRK2-associated parkinson disease population. JAMA
Neurology, 75(3), 312–319.
Senturk, Z. K. (2024). Enhancing parkinson’s disease prognosis with LSTM-based deep learning for precision diagnosis and symptom trajectory analysis. International Journal of Engineering Trends and Technology, 72(1), 53–66.
Simuni, T., et al. (2020). Clinical and dopamine transporter imaging characteristics of leucine rich repeat kinase 2 (LRRK2) and glucosylceramidase beta (GBA) parkinson’s disease participants in the parkinson’s progression markers initiative: A cross-sectional study. Movement Disorders, 35(5), 833–844.
Tong, R., Xu, T., Ju, X., & Wang, L. (2025a). Progress in medical AI: Reviewing large language models and multimodal systems for diagnosis. AI Med, 1(1), 5.
Tong, R., Liu, J., Liu, S., Hu, X., & Wang, L. (2025b). Renaissance of RNNs in streaming clinical time series: Compact recurrence remains competitive with transformers. arXiv preprint arXiv:2510.16677.
Tong, R., Liu, J., Liu, S., Xu, J., Wang, L., & Wang, T. (2025c). Does bigger mean better? Comparative analysis of CNNs and biomedical vision language models in medical diagnosis. arXiv preprint arXiv:2510.00411.
Tsanas, A., Little, M. A., McSharry, P. E., & Ramig, L. O. (2012). Accurate telemonitoring of parkinson’s disease progression by non-invasive speech tests. Journal of the Royal Society Interface, 9(75), 1905–1912.
UCI Machine Learning Repository. (2012). Parkinson’s disease telemonitoring data set [Data set]. https://archive.ics.uci.edu/ml/machine-learning-databases/parkinsons/telemonitoring/ parkinsons_updrs.data
Wang, J., et al. (2024). Personalized prediction of parkinson’s disease progression based on deep Gaussian processes.
Studies in Health Technology and Informatics, 310, 765–769.
Wood, S. N. (2011). Fast stable restricted maximum likelihood and marginal likelihood estimation of semiparametric generalized linear models. Journal of the Royal Statistical Society: Series B, 73(1), 3–36.
Wood, S. N. (2017). Generalized Additive Models: An Introduction with R (2nd ed.). Chapman & Hall/CRC.